Emad S. Alnemri, PhD
EMAD S. ALNEMRI, PhD, Thomas Eakins Professor of Biochemistry and Molecular Biology at the Sidney Kimmel Cancer Center–Jefferson Health, has been named a fellow of the National Academy of Inventors. The 2018 fellows will be inducted in a ceremony in April 2019, at the Space Center Houston during the National Academy of Inventors Eighth Annual Meeting in Houston.
The National Academy of Inventors Fellows Program was established in 2012 to highlight academic inventors and innovators. Those elected to the rank of National Academy of Inventors Fellow are named inventors on U.S. patents and are nominated by their peers for contributions to innovation in areas such as patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation.
Dr. Alnemri is a leader in the field of apoptosis. In the past 25 years, he has led research on the molecular pathways of apoptosis, resulting in the discovery of many protease enzymes that cleave cellular proteins during apoptosis and inflammation. His research on the function of inflammatory caspases led to the discovery of several inflammasome complexes, which are important for the production of inflammatory cytokines during inflammation and innate immune responses to pathogens. ■
